Target intelligence / Profile preview

Chediak-Higashi syndrome 1 pseudogene

Molecular classification
Other (pseudogene)
01

Overview

The **Chediak-Higashi syndrome 1 pseudogene** (ENSG00000235775) is a non-functional pseudogene related by sequence homology to the *LYST* gene, which encodes the lysosomal trafficking regulator protein. Chediak-Higashi syndrome (CHS) itself is a rare, autosomal recessive disorder caused by loss-of-function mutations in *LYST*, leading to defects in lysosome trafficking, oculocutaneous albinism, immune deficiency, and neurological dysfunction. The CHS1 pseudogene does not produce a functional protein and does not have known biological or clinical significance[1][7].\n\nKey clarification: \n- The biologically and clinically relevant gene in Chediak-Higashi syndrome is *LYST*, usually referred to as "lysosomal trafficking regulator". The pseudogene has no known role in disease mechanisms or diagnostics and is not a molecular target for therapy[1][7]. \n- If you are seeking information relevant to the disease or therapeutic intervention, you should refer to the functional *LYST* gene, not its pseudogene.\n\nIf "target" information is sought for drug discovery, *LYST* is the correct entity; this entry (ENSG00000235775) does not correspond to a molecular target.

Other names
CHS1 pseudogeneCHS1P

Beyond the preview

Go deeper on Chediak-Higashi syndrome 1 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chediak-Higashi syndrome 1 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call